{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:43:34Z","timestamp":1791189814561,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,4,29]],"date-time":"2003-04-29T00:00:00Z","timestamp":1051574400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1007\/s00280-003-0620-1","type":"journal-article","created":{"date-parts":[[2003,11,24]],"date-time":"2003-11-24T19:16:31Z","timestamp":1069701391000},"page":"13-18","source":"Crossref","is-referenced-by-count":182,"title":["Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial"],"prefix":"10.1007","volume":"52","author":[{"given":"Joseph T.","family":"Santoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Joseph A.","family":"Lucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Schafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward V.","family":"Hannigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,4,29]]},"reference":[{"key":"0620_CR1","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.1999.17.5.1339","volume":"17","author":"Whitney","year":"1999","unstructured":"Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, Clarke-Pearson DL, Liao SY (1999) Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17:1339\u20131348","journal-title":"J Clin Oncol"},{"key":"0620_CR2","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","volume":"340","author":"Morris","year":"1999","unstructured":"Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137\u20131143","journal-title":"N Engl J Med"},{"key":"0620_CR3","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","volume":"340","author":"Rose","year":"1999","unstructured":"Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144\u20131153","journal-title":"N Engl J Med"},{"key":"0620_CR4","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","volume":"340","author":"Keys","year":"1999","unstructured":"Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd, Walker JL, Gersell D (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154\u20131161","journal-title":"N Engl J Med"},{"key":"0620_CR5","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","volume":"18","author":"Peters","year":"2000","unstructured":"Peters WA III, Liu PY, Barrett RJ, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W Jr, Alberts DS (2000) Concurrent chemotherapy and pelvic radiation therapy as adjunctive therapy after radical surgery in high risk early stage carcinoma of the cervix. J Clin Oncol 18:1606\u20131613","journal-title":"J Clin Oncol"},{"key":"0620_CR6","first-page":"21","volume":"12","author":"Ozols","year":"1985","unstructured":"Ozols RF, Young RC (1985) High-dose cisplatin therapy in ovarian cancer. Semin Oncol 12:21\u201330","journal-title":"Semin Oncol"},{"key":"0620_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1006\/gyno.1993.1184","volume":"50","author":"Cornelison","year":"1993","unstructured":"Cornelison TL, Reed E (1993) Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin (review). Gynecol Oncol 50:147\u2013158","journal-title":"Gynecol Oncol"},{"key":"0620_CR8","first-page":"54","volume":"10","author":"Daugaard","year":"1987","unstructured":"Daugaard G, Abildgaard U, Larsen S (1987) Functional and histopathological changes in dog kidneys after administration of cisplatin. Renal Physiol 10:54\u201364","journal-title":"Renal Physiol"},{"key":"0620_CR9","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1073\/pnas.71.7.2777","volume":"71","author":"Clayton","year":"1974","unstructured":"Clayton DA, Doda JN, Fiedberg ED (1974) The absence of a pyrimidine dimer repair mechanism in mammalian mitochondria. Proc Natl Acad Sci U S A 71:2777\u20132781","journal-title":"Proc Natl Acad Sci U S A"},{"key":"0620_CR10","doi-asserted-by":"crossref","first-page":"F991","DOI":"10.1152\/ajpcell.1986.250.6.C932","volume":"250","author":"Gordon","year":"1986","unstructured":"Gordon JA, Gattone VH (1986) Mitochondrial alteration in cisplatin-induced acute renal failure. Am J Physiol 250:F991\u2013998","journal-title":"Am J Physiol"},{"key":"0620_CR11","unstructured":"Tisher CA (1981) Anatomy of the kidney. In: Brenner Rectors (eds) The kidney. Saunders, Philadelphia, pp 28\u201335"},{"key":"0620_CR12","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO;2-J","volume":"39","author":"Hayes","year":"1977","unstructured":"Hayes DM, Cvitkovic E, Goldberg RB, Scheiner E, Helson L, Krakoff IH (1977) High dose cis-platinum diammine chloride. Cancer 39:1372\u20131381","journal-title":"Cancer"},{"key":"0620_CR13","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/1097-0142(197405)33:5<1219::AID-CNCR2820330505>3.0.CO;2-U","volume":"33","author":"Higby","year":"1974","unstructured":"Higby DJ, Wallace HJ Jr, Albert DJ, Holland JF (1974) Diaminodichloroplatinum: a phase-I study showing responses in testicular and other tumors. Cancer 33:1219\u20131225","journal-title":"Cancer"},{"key":"0620_CR14","first-page":"31","volume":"66","author":"Al-Sarraf","year":"1982","unstructured":"Al-Sarraf M, Fletcher W, Oishi N (1982) Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a Southwest Oncology Group study. Cancer Treat Rep 66:31\u201335","journal-title":"Cancer Treat Rep"},{"key":"0620_CR15","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/1097-0142(197704)39:4<1357::AID-CNCR2820390402>3.0.CO;2-C","volume":"39","author":"Cvitkovic","year":"1977","unstructured":"Cvitkovic E, Spaulding J, Bethune V, Martin J, Whitmore WF (1977) Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model. Cancer 39:1357\u20131361","journal-title":"Cancer"},{"key":"0620_CR16","first-page":"73","volume":"65","author":"Ostrow","year":"1981","unstructured":"Ostrow O, Egorin MJ, Hahn D (1981) High dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity. Cancer Treat Rep 65:73\u201378","journal-title":"Cancer Treat Rep"},{"key":"0620_CR17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/clpt.1988.132","volume":"44","author":"Daugaard","year":"1988","unstructured":"Daugaard G, Abildgaard U, Holstein-Rathlou NH, Bruunshuus I, Bucher D, Leyssai PP (1988) Renal tubular function in patients treated with high-dose cisplatin. Clin Pharmacol Ther 44:164\u2013172","journal-title":"Clin Pharmacol Ther"},{"key":"0620_CR18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/1120009X.1990.11738971","volume":"2","author":"Sobrero","year":"1990","unstructured":"Sobrero A, Guglemi A, Aschele C, Rosso R (1990) Current strategies to reduce cisplatin toxicity. J Chemother 2:3\u20137","journal-title":"J Chemother"},{"key":"0620_CR19","first-page":"367","volume":"61","author":"Chary","year":"1977","unstructured":"Chary KK, Higby DJ, Henderson ES (1977) Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis. Cancer Treat Rep 61:367\u2013370","journal-title":"Cancer Treat Rep"},{"key":"0620_CR20","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/0360-3016(79)90677-1","volume":"5","author":"Lehane","year":"1979","unstructured":"Lehane D, Winston A, Gray R, Daskal Y (1979) The effect of diuretic pretreatment on clinical, morphological, and ultrastructural cis-platinum induced nephrotoxicity. Int J Radiat Oncol Biol Phys 5:1393\u20131399","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"0620_CR21","first-page":"201","volume":"19","author":"Gehr","year":"1981","unstructured":"Gehr M, Chopra S, Kaufman J, Chase D, Fjlamenbaum W (1981) The effect of furosemide on cis-diamminedichloroplatinum-induced acute renal failure. Kidney Int 19:201\u2013204","journal-title":"Kidney Int"},{"key":"0620_CR22","first-page":"375","volume":"61","author":"Ward","year":"1977","unstructured":"Ward JM, Grabin ME, LeRoy AF, Young DM (1977) Modification of the renal toxicity of cis-diamminedichloroplatinum (II) with furosemide in male F344 rats. Cancer Treat Rep 61:375\u2013379","journal-title":"Cancer Treat Rep"},{"key":"0620_CR23","unstructured":"Fisher DS, Knobf MT, Durivage HJ (1989) The cancer chemotherapy handbook, 4th edn. Mosby Yearbook, St. Louis"},{"key":"0620_CR24","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1177\/106002809302701219","volume":"27","author":"Anad","year":"1993","unstructured":"Anad AJ, Bashey B (1993) Newer insights into cisplatin nephrotoxicity. Ann Pharmacother 27:1519\u20131525","journal-title":"Ann Pharmacother"},{"key":"0620_CR25","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1200\/JCO.1992.10.5.706","volume":"10","author":"Alberts","year":"1992","unstructured":"Alberts DS, Green S, Hannigan EV, O'Toole R, Stock-Novack D, Anderson P, Surwit EA, Malvlya VK, Nahhas WA, Jolles CJ (1992) Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III & IV ovarian cancer. J Clin Oncol 10:706\u2013717","journal-title":"J Clin Oncol"},{"key":"0620_CR26","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.1996.14.7.2101","volume":"14","author":"Kemp","year":"1996","unstructured":"Kemp G, Rose P, Lurain J, Berman M, Manetta A, Roullet B, Homesley H, Belpomme D, Glick J (1996) Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer. J Clin Oncol 14:2101\u20132112","journal-title":"J Clin Oncol"},{"key":"0620_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/annurev.med.39.1.465","volume":"39","author":"Levey","year":"1988","unstructured":"Levey AS, Perrone RD, Madias NE (1988) Serum creatinine and renal function. Annu Rev Med 39:465\u2013490","journal-title":"Annu Rev Med"},{"key":"0620_CR28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00257365","volume":"21","author":"Daugaard","year":"1988","unstructured":"Daugaard G, Rossing N, Rorth M (1988) Effects of high dose cisplatin on glomerular function in the human kidney. Cancer Chemother Pharmacol 21:163\u2013167","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-003-0620-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-003-0620-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-003-0620-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-003-0620-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T18:14:43Z","timestamp":1581963283000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-003-0620-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,29]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["0620"],"URL":"https:\/\/doi.org\/10.1007\/s00280-003-0620-1","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4,29]]}}}